Trials in Rheumatology: IL-6 and Beyond

In this video, Leonard Calabrese, DO, and Cassandra Calabrese, DO, discuss their experiences with the COVID-19 pandemic, including the ongoing drug trials at the Cleveland Clinic. Read the transcript here.

Additional Resource:

• Feldman M, Maini RN, Woody JN, et al. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed [published online April 9, 2020]. Lancet. https://doi.org/10.1016/S0140-6736(20)30858-8

Leonard H. Calabrese, DO, is the head of the Section of Clinical Immunology, manager of the Clinical Immunology Clinic, and co-director of the Center for Vasculitis Care and Research at the Cleveland Clinic in Cleveland, Ohio.

Cassandra Calabrese, DO, holds joint appointments in the rheumatology department and the infectious disease department at the Cleveland Clinic in Cleveland, Ohio.